Navigation Links
Varian Medical Systems Selected to Supply Major Project to Bring Advanced Radiotherapy Treatments to North of Portugal
Date:10/30/2009

PORTO, Portugal, Oct. 30 /PRNewswire-FirstCall/ -- Cancer patients in northern Portugal will gain access to advanced cancer treatments with the acquisition of seven new treatments machines from Varian Medical Systems (NYSE: VAR) by the Instituto Portugues Oncologia, IPO Porto. The order, placed in August, includes the country's first Novalis Tx(TM) device for advanced radiosurgery and two Trilogy® medical linear accelerators offering RapidArc® radiotherapy capability.

The project involves complete reconstruction of an institute that first began treating cancer patients in 1974 and has offered top quality cancer care for north Portugal's 3.6m inhabitants since. Four Clinac® DHX linear accelerators, ARIA(TM) oncology information software with 64 workstations and 15 treatment planning systems also form part of the largest single radiotherapy order ever placed in Portugal. Varian has also signed an eight-year service contract with the institute.

"The efficacy of radiotherapy treatments is already very well known but the improvement in quality that will come from this project will be of enormous benefit to the quality of life of patients in the north of Portugal," said Helena Pereira, M.D., IPO's radio oncology service medical director. "This new equipment will allow us to introduce new radiation delivery techniques that offer more efficient and more precise ways of treating cancer while reducing side effects."

Laranja Pontes, M.D., the Institute's CEO, added, "We have been working with Varian for twenty years and we are very pleased with the relationship. The acquisition of this new equipment shows our faith in this relationship and our belief that Varian's equipment and software offer our patients the best treatments."

RapidArc delivers a precise and efficient treatment in single or multiple arcs of the treatment machine around the patient and makes it possible to deliver image-guided intensity modulated radiotherapy (IMRT) two to eight times faster than is possible with conventional IMRT. Faster treatments allow for greater precision, since there is less chance of patient or tumor movement during treatment delivery and, with less time on the treatment couch, also allow for greater patient comfort.

Novalis Tx from Varian and BrainLAB features very high dose delivery rates, which contributes to shorter treatment times. It also offers dynamic fine beam shaping using the HD-120 high definition multi-leaf collimator (MLC) and non-invasive, precise patient positioning. The integrated On-Board Imager® device pinpoints the target and enables positioning of the patient with millimeter precision.

"This is a bold and impressive project and we are delighted that IPO Porto has selected Varian equipment and software to equip it," says Michael Sandhu, head of Varian's Oncology Systems business in Europe. "When clinical treatments start, this equipment will make a huge difference to cancer patients in the region, not only in additional treatment machines but also in the use of more efficient procedures."

IPO Porto is a public health institution of international renown in the treatment, research and teaching of cancer, often treating the most complex cancer cases in the north of the country. In 2008, almost 3,000 new cancer patients were treated at the institute.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America, China, and Europe and in its 79 sales and support offices around the world. For more information, visit http://www.varian.com/

About IPO Porto

The Portuguese Oncology Institute, Porto Francisco Gentil (IPOP) was created in 1974. Its radiotherapy department has been treating non-stop for 35 years. IPOP's main mission is to deliver high quality, humanist and efficient oncology healthcare to the population of north Portugal. It also has a goal of developing innovative research, training and teaching methods within oncology. For more information, visit www.ipoporto.pt

SOURCE Varian Medical Systems, Inc.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Varian Medical Systems to Exhibit a Wide Selection of Flat Panel X-Ray Image Detectors and X-Ray Tubes at the CMEF Show in Chengdu, China
2. Varian, Inc. Delivers a Productivity Increase of Up to 100% With Its 710-ES Series ICP-OES
3. Farletuzumab Data Presented on Phase II Clinical Trial in First-Relapsed Ovarian Cancer Subjects
4. NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
5. Pivotal Registration Trial of OPAXIO Maintenance Therapy in First-Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients, Cell Therapeutics and the Gynecologic Oncology Group Discuss Potential for Early Interim Analysis
6. FDA Clears a Test for Ovarian Cancer
7. Cancer Treatment Centers of America(R) Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells
8. Oasmia: FDA Grants Paclical(R) Orphan Drug Designation for Ovarian Cancer in the USA
9. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
10. Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
11. Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)...  Lannett Company, Inc. (NYSE: LCI ) today announced ... Prescription for Success Healthcare Conference on December 14, 2016 at 9:20 ... York City . In addition, the company will ... 4 th Annual Boston Healthcare Conference taking place on December ... ...
(Date:12/6/2016)... CONCORD, Mass. , Dec. 6, 2016  Alopexx ... of DI-Leu16-IL2, a recombinant antibody fusion protein (immunocytokine) composed ... antibody recognizes the same target on B cells as ... and cytokine components but is also involved in tumor ... an anti-cancer vaccine effect. The results of the study ...
(Date:12/6/2016)... , Dec. 6, 2016 Diabetes & Obesity ... diabetes and obesity disease cluster is currently dominated by ... type 2 diabetes mellitus (T2DM), and the majority of ... of products, is attributable to these indications. While products ... market presence, there are a large number of these ...
Breaking Medicine Technology:
(Date:12/7/2016)... OAK BROOK, Ill. (PRWEB) , ... December 07, 2016 , ... ... linked to early-stage brain damage, according to a study appearing online in the journal ... the incidence is expected to increase significantly due to the rapidly aging population. Damage ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... financial consultation services to residents in the Sacramento/Folsom region, is initiating a charity ... facility. , The Another Choice Another Chance treatment center in Sacramento works to ...
(Date:12/7/2016)... AUSTIN, TX (PRWEB) , ... OCTOBER XX, 2016 ... ... may help solve another mystery. A new study entitled “Canine Filamentous Dermatitis ... Morgellons disease can occur in dogs. The study was published in the prestigious ...
(Date:12/7/2016)... ... 07, 2016 , ... Texas Premier Locksmith , a ... by unethical locksmith companies and is urging Search Engines to improve verification methods ... Premier Locksmith, these fraudulent locksmith services take advantage of consumers locked out of ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... WellnessPro Plus for consumers and healthcare professionals to manage chronic and acute ... the treatment modalities available in a single device. The announcement is part ...
Breaking Medicine News(10 mins):